medpundit |
||
|
Saturday, October 05, 2002The FDA said on Friday that the Lariam label had been changed to stress that the drug is contraindicated for preventive use in patients with active depression, recent history of depression, generalized anxiety disorder, psychosis, schizophrenia or other major psychiatric disorders. The new label also puts added stress on a contraindication for preventive use in patients with a history of convulsions, the agency noted. The drug, however, hasn't been implicated in the Fort Bragg violence, it's only being investigated. posted by Sydney on 10/05/2002 09:22:00 AM 0 comments 0 Comments: |
|